Akari Therapeutics plc ADS (AKTX) has no currently recruiting or active clinical trials where it is listed as lead sponsor on ClinicalTrials.gov.
AKTX has 1 Form 4 insider filing recorded at the SEC in the past 30 days[1].
Sources
- SEC EDGAR · 0001541157 (2026-04-11) ↗